SOURCE: Elsevier Business Intelligence

Windhover's Therapeutic Area Partnerships

October 30, 2009 13:13 ET

Windhover Expands Its List of Top Projects to Watch

NORWALK, CT--(Marketwire - October 30, 2009) - Elsevier Business Intelligence and Windhover Conferences have announced their complete Top 10 Projects to Watch for the upcoming Therapeutic Area Partnerships event, Nov. 17-19 in Boston, MA. This year's list will offer a Top 10 in each of four therapeutic areas: cardiovascular/metabolic, oncology, neuroscience and inflammatory/autoimmune. Past Windhover top 10 candidates signed a total potential value of $17 billion US in acquisitions and alliances. Confirmed participating companies include Lundbeck, Astellas, Biovail, Bristol-Myers Squibb, Biogen Idec, Millennim, Merck, Novartis, Eli Lilly, Genzyme, Merck and Company, Wyeth, GlaxoSmithKline, Merck Serono, Daiichi Sankyo, and AstraZeneca.

Complete details of all projects to date are available at Each project has been hand-selected by Windhover's elite selection panel to ensure a high-quality slate of presenters. The projects have met rigorous criteria including: unmet medical need, market potential, diversity of indications, strong science, multi-level partnering opportunities (biotech and pharma), potential for new opportunities beyond initial indications, and corporate stability.

Oncology companies on the list are TransMolecular, AngioChem, Ariad, Allos, Gloucester, Oncothyreon, Rexahn, Biothera, Infinity Pharmaceuticals and Cornerstone Pharmaceuticals.

Cardiovascular/metabolic companies are Aryx, XOMA, Array Biopharma, TransTech Pharma, Zafgen, Vitae, Galmed Medical Research, Celladon, Metabolex and Alnylam.

Neuroscience companies are EnVivo Pharmaceuticals Inc., NeurAxon Inc., Allon Therapeutics, Alexza, AFRAXIS, Karo Bio, CeNeRx, Trophos, Prana Biotechnology and Braincells.

Inflammatory/autoimmune companies are Enzo Biochem, Almirall, Orexo, Galactica Pharmaceuticals, Bayhill Therapeutics, Chelsea Therapeutics, LifeCycle Pharma, Lexicon Pharmaceuticals, and Synta Pharmaceuticals.

Companies will present the product's target and first indication(s); other compounds addressing the same target; the relative advantage of the compound; the clinical results to date and general clinical plan for the future; IP on the compound or target; and any partnerships the company currently holds on the compound. Registered attendees have access to pre-conference access to a database that includes detailed technical, non-confidential information on projects available for partnering (pre-clinical and clinical stage).

Industry analysts will open each Top 10 session with therapy area-specific discussions on Matchmaking in Drug Partnering: Identifying the Right Drugs and the Right Partners

A major partnering event

Therapeutic Area Partnerships is the industry's most targeted and efficient partnering meeting for life science companies seeking partnerships in the top therapeutic areas. Decision-makers (business development and R&D) focusing on these therapeutic categories can meet to develop strategic alliances between their companies. Also, attendees enjoy the personal and interactive setting that combines company presentations, 1:1 meetings and networking functions.

Online registration for Therapeutic Area Partnerships is available at

Attendees at Therapeutic Area Partnerships will use Windhover's industry-leading partnering software to pre-arrange and schedule partnership meetings. Other opportunities include capitalizing on potential new business and collaboration opportunities with the hottest TA-focused companies; networking with hundreds of potential pharmaceutical and biotech partners through 1:1 meetings, cocktail parties, luncheons and refreshment breaks; hear exciting new statistics, deal case studies and trends in therapeutic area partnering from an unbeatable line-up of senior level speakers; and taking back the most current conference and detailed information on delegates, their companies, projects and technologies.

Top-level executives to lead intriguing content sessions

Leading industry executives will discuss timely issues at Therapeutic Area Partnerships, including Therapeutic Area Partnering: Predicting Pharma Strategies in a Post Primary Care World with Elsevier Business Intelligence's Roger Longman; Who Is your Best Partner?: How Deals Differ in Various Therapeutic Areas; and Deal Structures that Allow Large and Small Companies to Share Risk.

Top industry executives and strategists to speak at Therapeutic Area Partnerships include Jeff Hanke, VP, Cancer Research, AstraZeneca; Peter Wirth, Executive Vice President, Legal and Corporate Development, Genzyme Corp.; and Dr. Jeremy Levin, Senior Vice President, Strategic Transactions, Bristol-Myers Squibb. Additional speakers are listed on the website.

Therapeutic Area Partnerships will also offer several in-depth workshops.

Global Sponsor for Therapeutic Area Partnerships is Campbell Alliance; Gold Industry Sponsors are Astellas, Merck & Co. and Sanofi Aventis; and Association Sponsor is the Licensing Executives Society. Regional Supporting Organization is BioteCanada; Neuroscience Advisor is NI Research; Inflammation Advisor is Healogix; Oncology Advisor is Campbell Alliance; and Cardiovascular/Metabolic Advisor is DefinedHealth. Media Partner is, and Major Supporting Publications are IN VIVO: The Business & Medicine Report™; Start-Up: Emerging Medical Ventures™; and "The Pink Sheet."

To register, contact Pat Cardone at (203) 838-4401 ext. 124 or; or register on the Therapeutic Area Partnerships 2009 website at

About Windhover Conferences and Elsevier Business Intelligence

Windhover Conferences is an Elsevier Business Intelligence company, the leading provider of business intelligence and analysis to senior executives in the medical device, pharmaceutical, and biotechnology industries. Publishers of IN VIVO: The Business & Medicine Report, Start-Up: Emerging Medical Ventures, The RPM Report: Regulation Policy Market Access, Medtech Insight, The Pink Sheet and The Pink Sheet Daily, Elsevier and Windhover also host a variety of industry meetings and webinars in both medical device and pharma/biotech, and produce a wide array of market research reports. For more on the companies' products and services, please visit

Contact Information